Proud brother! One step closer!!

Please share! 🙌🏽 Grateful for the opportunity to present today to the U.S. Senate Committee on Health, Education, Labor and Pensions Committee meeting on “What Can Congress Do to Address the Severe Shortage of Minority Health Care Professionals and the Maternal Health Crisis?”

NEWS FROM INDUSTRY
Results from the DESTINY-Breast06 trial indicate that trastuzumab deruxtecan🧪could become a new standard of care for #HER2 -low 🧬and HER2-ultralow metastatic #BreastCancer patients

➡️showing significant PFS improvements 📈over standard chemotherapy after

Andres F. Cardona y su visión del Fundación CTIC como un centro de tratamiento de Cáncer integral es más que necesaria en Colombia.

Gracias Dr. Cardona por ser un mentor y soñador, por guiar los pasos de muchos y por abrirnos las puertas para hacer ciencia. Le debemos mucho!

🇨🇴🇨🇴🇨🇴 Uniandes

Of 10 patients with relapsed or refractory hematologic cancers who received sequential CAR T-cell infusion followed by allogeneic stem-cell transplantation without GVHD prophylaxis, 6 were alive and disease-free at last follow-up. Read the full article: nej.md/4dqsTQ3

Science behind the Study: CAR T-Cell Therapy for Glioblastoma nej.md/49yGoKf

#Neurology

It’s a wrap! What great experience it was attending my first American College of Cardiology meeting ⭐️✅

Got to present our work, learned lots and connected with old friends & new colleagues. Until later Atlanta! #ACC24 🫀

We congratulate the recipient of the AACR Award for Lifetime Achievement in Cancer Research, Steven A. Rosenberg, MD, PhD, FAACR.
Dr. Rosenberg will present his Award Lecture at #AACR24 on Saturday, April 6, 3:00-3:45 PM. Learn more: bit.ly/3TDKGdb

'2024 is going to be the year of the TCR,' -Christopher Klebanoff, MD, Memorial Sloan Kettering Cancer Center. PICI Investigators, including Klebanoff_Lab, are advancing T cell receptor (TCR) treatments that may potentially surpass efficacy of CAR-based therapies. Learn more: bit.ly/48Z3k4R

New #JITC commentary: CARs are sharpening their weapons

Algún médico terminando su carrera interesado en hacer un internado especial en investigación en cáncer?

Brief Report: Intraventricular CARv3-TEAM-E T Cells in Recurrent Glioblastoma nej.md/3VnjUIq

#Neurology

Emma Stone wins the Academy Award for best actress for her role as Bella Baxter in “Poor Things.”

Stone applauded the fellow nominees in her category, including Lily Gladstone for her performance in “Killers of the Flower Moon.” wapo.st/4c9vyN1

And the Oscar for Best Actress goes to... Emma Stone! #Oscars

In a large trial of patients with recurrent high-grade gliomas, IL13Ra2-targeting #CARTcells were feasible to manufacture & well tolerated when delivered via intratumoral and/or intraventricular routes #glioblastoma City of Hope #BrainCancerAwarenessMonth
nature.com/articles/s4159…

Very happy to see our case published at Annals of Internal Medicine: Clinical Cases Facultad de Medicina - Universidad de los Andes Fundación Santa Fe de Bogotá Universidad El Bosque 🇨🇴

I am honored to share that I was selected as one of the incoming Chief Residents for UTHealth Houston Neurology Residency! Thanks to my colleagues and faculty for their support; I am excited about this new step in my career! 🧠 #Neurology #Residency #Education #Neurology Proud

FDA approves first tumour-infiltrating lymphocyte therapy, bolstering hopes for cell therapies in solid cancers bit.ly/49b0Q4p

Iovance’s lifileucel for patients with melanoma is the result of >30 years of research on this cell therapy modality bit.ly/3NldJQE

¡Ven y celebremos juntos! 💚

Hace 20 años empezó un proyecto que ha impactado la vida de miles de personas.

Este año tu Facultad está de cumpleaños, ¡Prepárate!

#20años #MediUniandes  
Uniandes